Nuveen Asset Management, LLC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 51 filers reported holding HARPOON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$231,000
-26.7%
51,0370.0%0.00%
Q4 2021$315,000
-26.9%
51,037
+3.6%
0.00%
Q3 2021$431,000
-73.6%
49,274
-58.2%
0.00%
Q2 2021$1,635,000
-19.5%
117,867
+21.4%
0.00%
-100.0%
Q1 2021$2,030,000
+23.9%
97,067
-1.6%
0.00%0.0%
Q4 2020$1,639,000
+14.0%
98,685
+16.6%
0.00%0.0%
Q3 2020$1,438,000
-50.4%
84,611
-51.5%
0.00%0.0%
Q2 2020$2,898,000
+71.2%
174,593
+19.4%
0.00%0.0%
Q1 2020$1,693,000
+626.6%
146,232
+828.5%
0.00%
Q4 2019$233,000
+8.4%
15,7490.0%0.00%
Q3 2019$215,00015,7490.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,524,425$58,818,00023.77%
New Leaf Venture Partners, L.L.C. 2,921,405$37,978,00010.18%
EcoR1 Capital, LLC 1,348,423$17,529,0001.77%
SPHERA FUNDS MANAGEMENT LTD. 374,031$4,862,0000.66%
Orbimed Advisors 2,446,409$31,803,0000.49%
Cormorant Asset Management, LP 649,994$8,450,0000.48%
Fosun International Ltd 323,400$4,205,0000.28%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 285,000$3,705,0000.13%
Baker Brothers Advisors 214,285$2,786,0000.02%
UBS Group AG 1,062$14,0000.00%
View complete list of HARPOON THERAPEUTICS INC shareholders